0001193125-07-175764 Sample Contracts

CONFIDENTIAL PROVISIONS REDACTED ASSIGNMENT AND PURCHASE AGREEMENT
Assignment and Purchase Agreement • August 8th, 2007 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California

THIS ASSIGNMENT AND PURCHASE AGREEMENT (the “Agreement”) is entered into this 25th day of April, 2007 (the “Effective Date”) by and among Resistys, Inc., a Delaware corporation having its principal place of business at 2121 Avenue of the Stars, Suite 2550, Los Angeles, California 90067 (“Resistys”), Avantogen Limited (formerly, Australian Cancer Technology Limited), an Australian corporation having its principal place of business at 2121 Avenue of the Stars, Suite 2550, Los Angeles, California 90067 (“Avantogen”), Avantogen Oncology, Inc. (formerly, Innovate Oncology, Inc.), a Nevada corporation having its principal place of business at 2121 Avenue of the Stars, Suite 2550, Los Angeles, California 90067 (“AOI”), and SciClone Pharmaceuticals, Inc. a Delaware corporation, having its principal place of business at 901 Mariners Island Blvd., San Mateo, California 94404 (“Buyer”) (Resistys, Avantogen and AOI also referred to herein individually and collectively as, “Seller”).

AutoNDA by SimpleDocs
CONFIDENTIAL PROVISIONS REDACTED AMENDED AND RESTATED LICENSE AGREEMENT
License Agreement • August 8th, 2007 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York

This Agreement, dated as of April 25, 2007 (“2007 Effective Date”), is by and between (i) SciClone Pharmaceuticals, Inc. (“SciClone”), a Delaware corporation having its principal place of business at 901 Mariners Island Blvd., San Mateo, California 94404, and (ii) RESprotect GmbH, a German corporation having an office at Fiedlerstr. 34, D-01307 Dresden, GERMANY (hereinafter “RESprotect”).

CONFIDENTIAL PROVISIONS REDACTED Supply Agreement for Licensed Product
Supply Agreement • August 8th, 2007 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations

**** Certain information on this page has been omitted and filed separately with the commission. Confidential treatment has been requested with respect to the omitted portions.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!